Statistics

Total Visits

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study9

Select a period of time:

Number of views in the range

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study7

Views

Views
November 20230
December 20232
January 20241
February 20240
March 20241
April 20241
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
Spain1
 

Top cities views

Views
Ashburn1
Boardman1
Chicago1
King George1
Vigo1